Skip to main content
. 2013 Apr 3;29(6):2109–2113. doi: 10.3892/or.2013.2381

Figure 2.

Figure 2

Bmal1 reduces the invasiveness of multiple types of cancer cells. (A) Human H1299 lung cancer and (B) U251 glioma cells were treated with Bmal1-targeting siRNAs or Bmal1-expressing vectors. After a 46-h incubation, cellular invasiveness was analyzed.